From Drug Benefit News - As health plans and PBMs consider how to address manufacturer-offered copay cards and other discounts on brand-name drugs — whether by encouraging their use among members, blocking the coupons or taking a more targeted approach — payers should keep a close watch on pharmaceutical manufacturers’ attempts to refine these programs to match competitors and gain market share. Read more
From Drug Benefit News - While this year’s 2015 Advance Notice issued by CMS on Feb. 21 contained a number of negative surprises for Medicare Advantage plans — including proposed changes that would lower MA plans’ base payment rates — the draft Call Letter portion of the document featured more minor tweaks to the Part D program and provisions that were already expected, like the termination of consistently low-performing plans. Read more
From Drug Benefit News - While proponents of value-based insurance design (VBID) say it can result in lower costs and higher quality of care, how to successfully design such programs and when to expect results continue to be debated and explored. Three new studies released this month examine the potential cost savings and improvements in adherence associated with pharmacy-centric VBID programs, including one article that suggests concurrent disease management may not be beneficial. And while… Read more
Check out all of the benefits, sample issues & more!